EP 4125827 A1 20230208 - DMEH ENHANCER
Title (en)
DMEH ENHANCER
Title (de)
DMEH - ENHANCER
Title (fr)
ACTIVATEUR À BASE DE DMEH
Publication
Application
Priority
- DE 102020107937 A 20200323
- EP 2021057247 W 20210322
Abstract (en)
[origin: CA3175480A1] The present invention relates to an administration form for transdermal administration of at least one active pharmaceutical ingredient having a logP = 3, comprising at least one penetration accelerator, wherein the at least one penetration accelerator comprises dimethylethyleneurea, to the use of such an administration form as medicament, and to the use of dimethylethyleneurea as penetration accelerator for increasing the skin penetration of active pharmaceutical ingredients having a logP = 3.
IPC 8 full level
A61K 9/70 (2006.01); A61K 31/12 (2006.01); A61K 31/4422 (2006.01); A61K 31/551 (2006.01); A61K 31/57 (2006.01)
CPC (source: EP US)
A61K 9/7038 (2013.01 - EP); A61K 9/7069 (2013.01 - US); A61K 9/7084 (2013.01 - EP); A61K 31/12 (2013.01 - EP); A61K 31/4422 (2013.01 - EP); A61K 31/551 (2013.01 - EP); A61K 31/5513 (2013.01 - US); A61K 31/57 (2013.01 - EP); A61K 47/18 (2013.01 - US)
Citation (search report)
See references of WO 2021191136A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
DE 102020107937 A1 20210923; BR 112022018374 A2 20221108; CA 3175480 A1 20210930; CN 115315255 A 20221108; EP 4125827 A1 20230208; JP 2023521953 A 20230526; US 2023104692 A1 20230406; WO 2021191136 A1 20210930
DOCDB simple family (application)
DE 102020107937 A 20200323; BR 112022018374 A 20210322; CA 3175480 A 20210322; CN 202180023953 A 20210322; EP 2021057247 W 20210322; EP 21713659 A 20210322; JP 2022557783 A 20210322; US 202117913747 A 20210322